Healthcare Costs

Mark Cuban thinks AI could transform healthcare, but it won’t fix opaque prices and broken incentives on its own. His starting point for employers: run every benefits contract through AI and ask where you’re getting ripped off. Mark joins a16z General Partner Julie Yoo and Erik Torenberg to discuss what he’s learned building Cost Plus Drugs, why trust is its core product, and how greater transparency could put pressure on healthcare costs. They also explore where AI can help, what personalized medicine could look like, how the role of doctors may change, and why Mark believes founders should use AI to learn, not as an excuse to stop thinking.

Dr. Jay Phipps is a serial entrepreneur, CEO of multiple companies, keynote speaker, and the visionary behind the Freedom from Fear tour. With a doctorate in pharmacy and over 25 years of business ownership, Dr. Phipps is known for his commitment to helping individuals and organizations conquer fear and unlock their true potential. Drawing from both personal experience and in-depth research, he empowers others with science-backed tools to overcome mental barriers, build confidence, and lead with resilience. Dr. Phipps is also the founder of Phipps Pharmacy, renowned for its community-rooted model and dedication to meeting people where they are. Known as the “Pharmacy Gladiator,” he continues to inspire others through his action-driven approach and infectious optimism.

Takeaways:

Fear Can Be a Bridge or a Barrier: Dr. Phipps emphasizes that everyone experiences fear, but it can either paralyze us or propel us toward our destiny if we learn to face it head-on and use it as motivation.

Visualization is a Powerful Tool Against Fear: The brain can’t distinguish between real and vividly imagined experiences. Practicing visualization helps rewire the mind for success, making it more likely we’ll conquer our fears in real situations.

Culture and Action Defeat Fear in Business: Building a resilient, change-positive culture in your business and taking swift, bold action are essential both for overcoming personal fears and for scaling while maintaining community values.

 Sound Bites:

“Fear can either be a barrier or a bridge between your dreams and your destiny.”

“Action is the antidote for fear…every time you conquer a fear, you actually restructure your amygdala, your fear center.”

“You want to be the thermostat, not the thermometer in the room. You want to control the energy and look for solutions, not problems.”

Connect & Discover Jay:

Instagram: https://www.instagram.com/drjayphipps/

LinkedIn: https://www.linkedin.com/in/drjayphipps/

Website: https://pharmacygladiator.com/

🔥 Ready to Unleash Your Inner Game-Changer? 🔥

 

Mick Hunt’s brand-new book, How to Be a Good Leader When You’ve Never Had One: The Blueprint for Modern Leadership, is here to light a fire under your ambition and arm you with the real-talk strategies that only Mick delivers.

 

👉 Grab your copy now and level up your life → Amazon, Barnes & Noble, Books A Million

 

FOLLOW MICK ON:

Spotify: MickUnplugged

Instagram: https://www.instagram.com/mickunplugged/

Facebook: https://www.facebook.com/mickunplugged/  

YouTube:  https://www.youtube.com/@MickUnpluggedPodcast

LinkedIn: https://www.linkedin.com/in/mickhunt/

Website:  https://mickhuntofficial.com/

Apple: MickUnplugged

Learn more about your ad choices. Visit megaphone.fm/adchoices

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Get more information about our first-ever live show here! Tickets go on sale Friday, September 5 at 10am ET. A hospital in Chester, Pennsylvania was acquired by a private equity firm that leveraged it to make shareholders millions. Now the facility has had to close its doors, leaving the community reeling. WSJ's Soma Biswas takes us inside the hospital’s bankruptcy and Jessica Mendoza speaks to a local emergency services executive about the impact on the local community in Chester.  Further Listening:  - Why Private Equity Is Buying Up Car Washes - The Private Equity Lobby Wins Again Sign up for WSJ’s free What’s News newsletter.  Learn more about your ad choices. Visit megaphone.fm/adchoices

Mathew Knowles is a visionary entrepreneur, renowned music executive, and esteemed educator best known for his instrumental role in launching and managing the careers of Destiny's Child and Beyoncé. As a third-generation entrepreneur with a background in corporate diagnostic imaging and technology sales, Mathew's expertise spans talent development, global brand building, and health advocacy. A passionate advocate for wellness and cancer prevention—himself a male breast cancer survivor—he champions early detection and genetic awareness, while consistently empowering others with his decades of experience, adaptability, and commitment to leadership and education.

Takeaways:

• The Power of Passion and Consistency: Mathew credits his enduring success to a relentless passion for his work, emphasizing that passion—paired with strong work ethic and consistency—fuels greatness and allows leaders to stay relevant across changing times and industries.

• The Importance of Early Detection: Drawing from his cancer survivor journey and background in diagnostic imaging, Mathew underscores the lifesaving value of early health screenings and genetic testing, especially within communities of color, advocating for a proactive approach over a reactive one.

• Brand Building Beyond the Surface: Mathew details his branding philosophy, explaining that both individuals and businesses must see themselves as brands, and that successful brands convey their value not just through words but through optics, actions, and strategic messaging.

Sound Bites:

“We are all individually as well as in our corporate careers as well as in entrepreneurship, we are a brand. The moment we walk outside the door, we're messaging to the world.”

“Passion and work ethics go together like a glove. When you live your passion, you never work—you work when you have a job.”

“Early detection is the key. For something that could take 30 minutes or two hours of your day…it can determine if you're going to be in one of those stages or if you're at risk.”

Connect & Discover Mathew:

Event Link: Touch4Life

Instagram: https://www.instagram.com/mrmathewknowles/?hl=en

Website: https://www.mathewknowles.com/

X: https://x.com/mathewknowles?lang=en

Facebook: https://www.facebook.com/mrmathewknowles/

🔥 Ready to Unleash Your Inner Game-Changer? 🔥

 

Mick Hunt’s brand-new book, How to Be a Good Leader When You’ve Never Had One: The Blueprint for Modern Leadership, is here to light a fire under your ambition and arm you with the real-talk strategies that only Mick delivers.

 

👉 Grab your copy now and level up your life → Amazon, Barnes & Noble, Books A Million 

 

FOLLOW MICK ON:

Spotify: MickUnplugged

Instagram: https://www.instagram.com/mickunplugged/

Facebook: https://www.facebook.com/mickunplugged/  

YouTube:  https://www.youtube.com/@MickUnpluggedPodcast

LinkedIn: https://www.linkedin.com/in/mickhunt/

Website:  https://mickhuntofficial.com/

Apple: MickUnplugged

Learn more about your ad choices. Visit megaphone.fm/adchoices

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Global diamond company De Beers spent decades convincing couples that true love required a diamond. But now, lab-grown diamonds that are identical to naturally-mined ones are flooding the market with cheaper options and reshaping the diamond business completely. WSJ’s Jenny Strasburg takes us inside the showdown in the diamond market, and we speak to a ring shopper weighing her options. Jessica Mendoza hosts. Further Listening:-One American Company Taking on China's Rare-Earth Dominance-Can Pepsi Make a Comeback?-How Target Got Off TargetSign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

UnitedHealth is the largest healthcare company in the U.S. But over the last 18 months, a string of challenges, including several Justice Department probes, have tested the company. WSJ’s Anna Wilde Mathews and Christopher Weaver report on how the company rose to prominence, why its CEO is out, and how it has weathered the setbacks. Annie Minoff hosts.   Further Listening:  -Medicare, Inc. Part 1: How Insurers Make Billions From Medicare  -Medicare, Inc. Part 2: Taxpayers Paid for Care Denied by Insurers  Sign up for WSJ’s free What’s News newsletter.  Learn more about your ad choices. Visit megaphone.fm/adchoices

Some of the sickest Medicare Advantage patients ran into problems getting end-of-life care. Ultimately many patients switched to traditional Medicare, costing taxpayers billions, according to an investigation by the Wall Street Journal. This is one of many Medicare Advantage practices that is now under government scrutiny. Both Congress and Medicare agency head Dr. Mehmet Oz are pushing for reforms to curb tactics that can boost federal payments to private insurers. The Department of Justice is also investigating major private insurance companies UnitedHealth, Aetna, Elevance Health and Humana. Jessica Mendoza discusses the investigations with WSJ’s Anna Wilde Mathews. Further Listening: -Medicare, Inc. Part 1: How Insurers Make Billions From Medicare  -A Life-or-Death Insurance Denial  Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

The FDA’s approval of a new pill that treats postpartum depression could be yet another signal that we are living in a golden age of medicine. This episode was produced by Jon Ehrens, edited by Amina Al-Sadi, fact-checked by Laura Bullard, engineered by Patrick Boyd, and hosted by Sean Rameswaram. Transcript at vox.com/todayexplained Support Today, Explained by making a financial contribution to Vox! bit.ly/givepodcasts Learn more about your ad choices. Visit podcastchoices.com/adchoices

The drug that brings people overdosing on opioids back from the brink of death in minutes just got approved for over-the-counter use. The Wall Street Journal’s Julie Wernau explains why she carries it with her everywhere she goes. This episode was produced by Hady Mawajdeh, edited by Jolie Myers, fact-checked by Laura Bullard, engineered by Paul Robert Mounsey, and hosted by Sean Rameswaram. Transcript at vox.com/todayexplained   Help keep this show and all of Vox's journalism free by making a gift to Vox today: bit.ly/givepodcasts Learn more about your ad choices. Visit podcastchoices.com/adchoices

Scientists have developed a long-sought treatment — perhaps even a cure — for sickle cell anemia. But getting it to patients might be an even bigger challenge. This episode was produced by Miles Bryan, edited by Matt Collette, fact-checked by Laura Bullard and Victoria Dominguez, engineered by Efim Shapiro, and hosted by Sean Rameswaram. Transcript at vox.com/todayexplained   Support Today, Explained by making a financial contribution to Vox! bit.ly/givepodcasts Learn more about your ad choices. Visit podcastchoices.com/adchoices

After 20 years of waiting, there’s a new drug to treat Alzheimer’s. For some patients, it’s a glimmer of hope. For some scientists, it’s one of the FDA’s worst drug approval decisions ever. Transcript at vox.com/todayexplained. Support Today, Explained by making a financial contribution to Vox! bit.ly/givepodcasts. Learn more about your ad choices. Visit podcastchoices.com/adchoices

The Atlantic's James Hamblin explains why America has a critical shortage of medical supplies. New York City ER doctor Calvin Sun says, “It’s like a lottery that we don’t want to play, but we’re forced to play.” (Transcript here.) Learn more about your ad choices. Visit podcastchoices.com/adchoices

Alexandria Ocasio-Cortez and the Trump administration agree on one thing: the cost of HIV drugs is too high. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Prosecutors, seeking to hold someone accountable for the opioid epidemic, have been targeting doctors, dealers and users themselves. But those who made billions of dollars from sales of OxyContin, a painkiller at the center of the crisis, have gone largely unpunished. Guest: Barry Meier, the author of “Pain Killer: An Empire of Deceit and the Origin of America’s Opioid Epidemic,” who has reported on Purdue Pharma and the opioid crisis for The New York Times. For more information on today’s episode, visit nytimes.com/thedaily.

Peter Attia is the founder of Attia Medical, PC, a medical practice with offices in San Diego and New York City, focusing on the applied science of longevity. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Dr. Mark Gordon is the Medical Director of Education at Access Medical Laboratory and is recognized as a top leader world wide in Interventional Endocrinology (Anti Aging Medicine). Andrew Marr is a former Green Beret and founder of the Warrior Angels Foundation. http://www.warriorangelsfoundation.org/ Learn more about your ad choices. Visit podcastchoices.com/adchoices